XML 19 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Total
Redeemable Convertible Preferred Stock
Redeemable Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Balance at Dec. 31, 2021 $ 41,089     $ 31 $ 443,752 $ (402,694)
Balance (in shares) at Dec. 31, 2021       31,409,707    
Stock-based compensation expense 515       515  
Stock-based compensation expense, shares       32,684    
Issuance of common stock from stock grants 16       16  
Issuance of common stock from stock grants, shares       34,662    
Net income (loss) (14,536)         (14,536)
Balance at Mar. 31, 2022 27,084     $ 31 444,283 (417,230)
Balance (in shares) at Mar. 31, 2022       31,477,053    
Balance at Dec. 31, 2021 41,089     $ 31 443,752 (402,694)
Balance (in shares) at Dec. 31, 2021       31,409,707    
Net income (loss) 37,096          
Balance at Jun. 30, 2022 79,062     $ 31 444,629 (365,598)
Balance (in shares) at Jun. 30, 2022       31,477,053    
Balance at Mar. 31, 2022 27,084     $ 31 444,283 (417,230)
Balance (in shares) at Mar. 31, 2022       31,477,053    
Stock-based compensation expense 346       346  
Net income (loss) 51,632         51,632
Balance at Jun. 30, 2022 79,062     $ 31 444,629 (365,598)
Balance (in shares) at Jun. 30, 2022       31,477,053    
Balance at Dec. 31, 2022 (21,689)     $ 37 389,210 (410,936)
Temporary equity, Balance (in shares) at Dec. 31, 2022   12,340 0      
Temporary equity, Balance at Dec. 31, 2022   $ 33,309 $ 0      
Balance (in shares) at Dec. 31, 2022       37,756,574    
Stock-based compensation expense 210       210  
Issuance of common stock from stock grants 2       2  
Issuance of common stock from stock grants, shares       3,251    
CVR cash dividends paid related to GCBP Agreement ($0.01 per share) (206)       (206)  
CVR derivative liability (4,530)       (4,530)  
Net income (loss) 260         260
Balance at Mar. 31, 2023 (25,953)     $ 37 384,686 (410,676)
Temporary Equity, Balance (in shares) at Mar. 31, 2023   12,340        
Temporary Equity, Balance at Mar. 31, 2023   $ 33,309        
Balance (in shares) at Mar. 31, 2023       37,759,825    
Balance at Dec. 31, 2022 $ (21,689)     $ 37 389,210 (410,936)
Temporary equity, Balance (in shares) at Dec. 31, 2022   12,340 0      
Temporary equity, Balance at Dec. 31, 2022   $ 33,309 $ 0      
Balance (in shares) at Dec. 31, 2022       37,756,574    
Issuance of common stock from option exercises, shares 215,067          
CVR derivative liability $ (4,530)          
Net income (loss) (2,212)          
Balance at Jun. 30, 2023 (28,314)     $ 37 384,797 (413,148)
Temporary Equity, Balance (in shares) at Jun. 30, 2023   12,340 37,975      
Temporary Equity, Balance at Jun. 30, 2023   $ 33,309 $ 0      
Balance (in shares) at Jun. 30, 2023       37,974,892    
Balance at Mar. 31, 2023 (25,953)     $ 37 384,686 (410,676)
Temporary equity, Balance (in shares) at Mar. 31, 2023   12,340        
Temporary equity, Balance at Mar. 31, 2023   $ 33,309        
Balance (in shares) at Mar. 31, 2023       37,759,825    
Stock-based compensation expense 89       89  
Issuance of common stock from option exercises 22       22  
Issuance of common stock from option exercises, shares       215,067    
Issuance of preferred stock for stock dividends, shares     37,975      
Net income (loss) (2,472)         (2,472)
Balance at Jun. 30, 2023 $ (28,314)     $ 37 $ 384,797 $ (413,148)
Temporary Equity, Balance (in shares) at Jun. 30, 2023   12,340 37,975      
Temporary Equity, Balance at Jun. 30, 2023   $ 33,309 $ 0      
Balance (in shares) at Jun. 30, 2023       37,974,892